دورية أكاديمية

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

التفاصيل البيبلوغرافية
العنوان: Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial
المؤلفون: Rodler, Eve, Sharma, Priyanka *, Barlow, William E, Gralow, Julie R, Puhalla, Shannon L, Anders, Carey K, Goldstein, Lori, Tripathy, Debu, Brown-Glaberman, Ursa A, Huynh, Thu-Tam, Szyarto, Christopher S, Godwin, Andrew K, Pathak, Harsh B, Swisher, Elizabeth M, Radke, Marc R, Timms, Kirsten M, Lew, Danika L, Miao, Jieling, Pusztai, Lajos, Hayes, Daniel F, Hortobagyi, Gabriel N
المصدر: In The Lancet Oncology February 2023 24(2):162-174
قاعدة البيانات: ScienceDirect
الوصف
تدمد:14702045
DOI:10.1016/S1470-2045(22)00739-2